| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.77M | 13.00M | 71.05M | 11.47M | 21.87M | 6.08M |
| Gross Profit | 30.45M | 2.89M | 1.33M | -59.54M | -35.10M | -48.70M |
| EBITDA | -1.33M | 533.66M | 26.07M | 6.68M | 8.84M | -24.71M |
| Net Income | 349.80M | 349.80M | -87.52M | -31.66M | -45.65M | -25.45M |
Balance Sheet | ||||||
| Total Assets | 1.19B | 1.19B | 1.24B | 1.14B | 1.08B | 1.09B |
| Cash, Cash Equivalents and Short-Term Investments | 181.34M | 181.34M | 135.88M | 114.79M | 158.97M | 141.34M |
| Total Debt | 55.40M | 55.40M | 271.80M | 199.58M | 161.93M | 151.37M |
| Total Liabilities | 323.13M | 323.13M | 441.97M | 354.73M | 336.29M | 323.60M |
| Stockholders Equity | 668.59M | 668.59M | 250.72M | 348.85M | 328.89M | 331.87M |
Cash Flow | ||||||
| Free Cash Flow | 17.05M | 17.05M | -87.96M | -296.67M | -188.69M | -231.79M |
| Operating Cash Flow | 17.09M | 17.09M | -87.88M | -130.43M | -74.55M | -97.92M |
| Investing Cash Flow | 350.21M | 284.10M | 62.06M | 30.56M | 163.47M | 46.80M |
| Financing Cash Flow | -339.79M | -273.69M | 47.47M | 57.82M | -74.29M | 3.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | AU$237.74M | 9.44 | 95.31% | ― | 19.38% | ― | |
65 Neutral | AU$1.10B | 11.01 | 12.11% | 11.11% | -6.49% | -5.40% | |
58 Neutral | $449.76M | 1.26 | 73.00% | ― | -22.61% | ― | |
57 Neutral | AU$953.62M | 10.13 | 11.07% | 4.85% | 5.01% | 85.56% | |
52 Neutral | AU$104.14M | 15.20 | 12.72% | ― | -0.51% | ― | |
42 Neutral | AU$89.11M | -1.32 | -42.59% | ― | -9.56% | -392.31% |
Omni Bridgeway Limited announced a change in the director’s interests, specifically regarding Raymond van Hulst’s holdings. The update includes the vesting of 22,520 FY23 performance rights and the lapse of 90,080 FY23 performance rights, alongside the cancellation of 1,900 B class shares. This adjustment in holdings reflects the company’s ongoing commitment to aligning executive interests with shareholder value, potentially impacting market perceptions and investor confidence.
Omni Bridgeway Limited has announced the application for the quotation of securities on the ASX, with 799,259 ordinary fully paid shares to be issued. These shares are a result of adjustments made to the FY23 performance rights granted to eligible employees, following the lapse of certain conditional rights.
Omni Bridgeway Limited announced the issuance of 799,259 ordinary fully paid shares as part of its FY23 Long Term Incentive Plan, which was evaluated based on portfolio growth. The remaining 80% of performance rights, linked to total shareholder return, lapsed. This move allows the shares to be sold under an exemption in section 708A(5) of the Corporations Act, ensuring compliance with regulatory requirements and maintaining transparency with investors.
Omni Bridgeway reported strong investment performance for the first quarter ending September 30, 2025, with cash investment proceeds totaling A$136.6 million and a multiple-on-invested-capital of 2.8x. The company also noted a robust pipeline with significant new commitments and settlements, indicating positive portfolio developments and a strong market position.
Omni Bridgeway Limited announced the results of its Annual General Meeting, where all resolutions put forward were carried. The meeting saw strong shareholder support, with the highest approval rating reaching 99.80% for one of the resolutions, indicating a positive reception from stakeholders and a stable outlook for the company.
Omni Bridgeway Limited announced the issuance and conversion of unquoted equity securities, totaling 52,213 ordinary fully paid shares. This move is part of the company’s ongoing efforts to manage its capital structure and support its strategic objectives, potentially impacting its market positioning and stakeholder interests.
Omni Bridgeway Limited has announced the issuance of 48,082 performance rights as part of an employee incentive scheme. This move is expected to enhance employee engagement and align their interests with the company’s strategic goals, potentially strengthening its market position in the legal finance sector.
Omni Bridgeway Limited has announced its annual general meeting, scheduled to take place on October 28, 2025, at the Amora Jamison Hotel in Sydney. The meeting will address various resolutions, and shareholders are encouraged to review the Explanatory Memorandum for detailed information on the matters to be discussed. This meeting is a critical event for stakeholders as it will influence the company’s strategic direction and governance.